Skip to main content

Advertisement

Table 3 Effect of cisplatin (CP) and different treatments of AHE on lung tissue protein, oxidative stress markers and lipid peroxidation

From: Acacia hydaspica R. Parker ameliorates cisplatin induced oxidative stress, DNA damage and morphological alterations in rat pulmonary tissue

Group Protein (μg/mg Tissue) H2O2 (nM/min/mg Tissue) Nitrite (content μM/ml) MDA (nM/min/mg protein)
Control 1.722 ± 0.042b 2.192 ± 0.025b 44.59 ± 0.609b 3.66 ± 0.265b
CP 0.965 ± 0.072a 5.752 ± 0.081a 82.16 ± 1.531a 8.649 ± 0.403a
AHE lone 1.711 ± 0.056b 2.148 ± 0.034b 44.26 ± 0.385b 3.599 ± 0.245b
CP + AHE 1.237 ± 0.025a,b*,d** 4.498 ± 0.073a,b,d 68.14 ± 0.81a,b,d 6.965 ± 0.214a,b**,d
AHE + CP 1.582 ± 0.040b,c** 3.049 ± 0.136a,b,c 50.53 ± 0.410a**,b,c 4.614 ± 0.184b,c
CP + Sily 1.591 ± 0.075b 2.99 ± 0.012a,b 50.03 ± 1.149a*,b 4.396 ± 0.208b
  1. Values expressed as mean ± SEM. a: Significance at p < 0.0001 Vs. control group, b: Significance at p < 0.0001 Vs. Cisplatin (CP) group. c: Significance at p < 0.0001 of AHE + CP pre-treated group Vs. CP + AHE post-treated group. d: Significance at p < 0.0001 of CP + AHE treatment groups Vs CP + Sily group. *, **: Significant difference at < 0.05 and p < 0.001 respectively. Non-significant difference (p > 0.05) was recorded between control and AHE alone treated group in all parameters (One way ANOVA followed by Tukey’s multiple comparison tests)